XML 41 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Schedule of the components of income tax benefit
The components of the income tax expense (benefit) for continuing operations are as follows (in thousands):
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
Current expense (benefit):
 
 
 
 
 
 
Federal
$
11

 
$
15

 
$

 
State
7

 
19

 
33

 
 
18

 
34

 
33

 
Deferred expense (benefit):
 
 
 
 
 
 
Federal
(193,398
)
 
406

 
404

 
State
(26,216
)
 
(30
)
 
(63
)
 
 
$
(219,596
)
 
$
410

 
$
374

 
Schedule of deferred tax assets and liabilities
Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2015 and 2014 are shown below. The Company assesses the positive and negative evidence to determine if sufficient future taxable income will be generated to use the existing deferred tax assets. During the third quarter of the year, the Company's evaluation of evidence resulted in management concluding that the majority of the Company's deferred tax assets will be realized. However, the Company maintains a valuation allowance to offset certain net deferred tax assets as management believes realization of such assets are uncertain as of December 31, 2015, 2014 and 2013. The valuation allowance decreased $230.7 million in 2015, decreased $9.8 million in 2014 and decreased $5.4 million in 2013.
 
 
December 31,
 
2015
 
2014
 
(in thousands)
Deferred assets:
 
 
 
Net operating loss carryforwards
$
188,076

 
$
193,747

Research and AMT credit carryforwards
25,613

 
28,288

Fixed assets and intangibles
8,839

 
13,237

Accrued expenses
1,523

 
1,579

Contingent liabilities
707

 
579

Deferred revenue
3

 
771

Present value of royalties
3,007

 
11,686

Organon termination asset

 
(111
)
Organon termination liability

 
111

Deferred rent
68

 
730

Other
17,281

 
5,780

 
245,117

 
256,397

Valuation allowance for deferred tax assets
(9,066
)
 
(240,420
)
Net deferred tax assets
$
236,051

 
$
15,977

Deferred tax liabilities:
 
 
 
Retrophin fair value adjustment
$
(1,256
)
 
$
(1,396
)
Convertible debt
(1,844
)
 
(1,436
)
Identified intangibles
(12,770
)
 
(13,146
)
Identified indefinite lived intangibles
(3,617
)
 
(3,048
)
Total
$
216,564

 
$
(3,049
)
Schedule of effective income tax rate reconciliation
A reconciliation of income tax expense (benefit) from continuing operations to the amount computed by applying the statutory federal income tax rate to the net income (loss) from continuing operations is summarized as follows:
 
 
Year Ended December 31,
 
2015
 
2014
 
2013
Amounts computed at statutory federal rate
$
(13,198
)
 
$
(3,843
)
 
$
(3,131
)
State taxes net of federal benefit
(386
)
 
(697
)
 
(293
)
Meals & entertainment
(16
)
 
(9
)
 
(10
)
Imputed interest
161

 
(53
)
 
(285
)
Section 162(m) limitation
(197
)
 
(490
)
 

Contingent liabilities
(1,684
)
 
(1,748
)
 
(2,027
)
Stock-based compensation
(140
)
 
(89
)
 
556

Expired NOLs
(232
)
 
(88
)
 

Research and development credits
(304
)
 
113

 
4,581

Change in uncertain tax positions
293

 
(7
)
 
(364
)
Rate change for changes in state law
5,756

 
(119
)
 
(901
)
Increase in deferred tax assets from completion of 382 analysis
(3,329
)
 
(43
)
 
(786
)
Avinza true up
2,107





Change in valuation allowance
231,370

 
7,243

 
3,509

Other
(605
)
 
(580
)
 
(1,223
)
 
$
219,596

 
$
(410
)
 
$
(374
)
Schedule of unrecognized tax benefits
A reconciliation of the amount of unrecognized tax benefits at December 31, 2015 and 2014 is as follows (in thousands):
 
Balance at December 31, 2013
$
8,504

     Additions based on tax positions related to the current year
40

     Additions for tax positions of prior years
(20
)
Balance at December 31, 2014
$
8,524

     Additions based on tax positions related to the current year
154

     Additions based on tax positions related to prior years
219

     Reductions for tax positions of prior years
(450
)
Balance at December 31, 2015
$
8,447